{"1R3.F": {"short_name": "IZOTROPIC CORP.", "long_name": "Izotropic Corporation", "summary": "Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.", "currency": "EUR", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "FRA", "market": "dr_market", "country": "Canada", "city": "Surrey"}, "20B.F": {"short_name": "BIOMARK DIAGNOSTICS INC.", "long_name": "Biomark Diagnostics Inc", "summary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.", "currency": "EUR", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "FRA", "market": "dr_market", "country": "Canada", "city": "Richmond"}, "3D0A.F": {"short_name": "TELO GENOMICS CORP. O.N.", "long_name": "Telo Genomics Corp.", "summary": "Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada.", "currency": "EUR", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "FRA", "market": "dr_market", "country": "Canada", "city": "Toronto"}, "8VP1.F": {"short_name": "AVRICORE HEALTH INC.", "long_name": "Avricore Health Inc.", "summary": "Avricore Health Inc. operates as a healthcare technology company in Canada. The company provides HealthTab, a lab-accurate point of care testing platform. In addition, it offers Corozon Platform, which consists of Corozon Academy that provides practical professional education to community pharmacists; and Corozon Hardware, an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.", "currency": "EUR", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "FRA", "market": "dr_market", "country": "Canada", "city": "Vancouver"}, "AKU": {"short_name": "Akumin Inc.", "long_name": "Akumin Inc.", "summary": "Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "NMS", "market": "us_market", "country": "Canada", "city": "Toronto"}, "AKU.TO": {"short_name": "AKUMIN INC", "long_name": "Akumin Inc.", "summary": "Akumin Inc. provides outpatient diagnostic imaging services in the United States. As of December 31, 2019, the company operated 129 imaging centers located in Florida, Pennsylvania, Delaware, Georgia, Texas, Illinois, and Kansas. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders, and reduce unnecessary invasive procedures. The company provides a range of medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, radiology, and other diagnostic or interventional radiology procedures; and online medical bill payment services. Akumin Inc. is headquartered in Toronto, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "TOR", "market": "ca_market", "country": "Canada", "city": "Toronto"}, "AVCR.V": {"short_name": "AVRICORE HEALTH INC", "long_name": "Avricore Health Inc.", "summary": "Avricore Health Inc. operates as a healthcare technology company in Canada. The company provides HealthTab, a lab-accurate point of care testing platform. In addition, it offers Corozon Platform, which consists of Corozon Academy that provides practical professional education to community pharmacists; and Corozon Hardware, an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "VAN", "market": "ca_market", "country": "Canada", "city": "Vancouver"}, "AVCRF": {"short_name": "AVRICORE HEALTH INC", "long_name": "Avricore Health Inc.", "summary": "Avricore Health Inc. operates as a healthcare technology company in Canada. The company provides HealthTab, a lab-accurate point of care testing platform. In addition, it offers Corozon Platform, which consists of Corozon Academy that provides practical professional education to community pharmacists; and Corozon Hardware, an e-commerce portal that allows pharmacists to order point-of-care diagnostic devices and supplies. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Vancouver"}, "BMKDF": {"short_name": "BIOMARK DIAGNOSTICS INC", "long_name": "Biomark Diagnostics Inc", "summary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Richmond"}, "BUX.CN": {"short_name": "BioMarkDiagnos", "long_name": "Biomark Diagnostics Inc", "summary": "Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions that allow for cancer detection, monitoring, and assessing treatment. The company has a collaboration with the University of Maryland School of Medicine related to the discovery and validation of BioMark's assays for early lung cancer and monitoring of residual tumor load/activity. The company was incorporated in 2014 and is headquartered in Richmond, Canada. Biomark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "CNQ", "market": "ca_market", "country": "Canada", "city": "Richmond"}, "CGN.CN": {"short_name": "CognetivityNeu", "long_name": "Cognetivity Neurosciences Ltd.", "summary": "Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical and commercial environments for potentially allowing early diagnosis of dementia. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "CNQ", "market": "ca_market", "country": "Canada", "city": "Vancouver"}, "CGNH": {"short_name": "CARDIOGENICS HOLDINGS INC", "long_name": "CardioGenics Holdings Inc", "summary": "CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Mississauga"}, "CGNSF": {"short_name": "COGNETIVITY NEUROSCIENCES LTD", "long_name": "Cognetivity Neurosciences Ltd.", "summary": "Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical and commercial environments for potentially allowing early diagnosis of dementia. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Vancouver"}, "EDT.TO": {"short_name": "SPECTRAL MEDICAL INC", "long_name": "Spectral Medical Inc.", "summary": "Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, produces, and markets recombinant proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy and continuous renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "TOR", "market": "ca_market", "country": "Canada", "city": "Toronto"}, "EDTXF": {"short_name": "SPECTRAL MEDICAL INC", "long_name": "Spectral Medical Inc.", "summary": "Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, produces, and markets recombinant proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy and continuous renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Toronto"}, "EIY2.F": {"short_name": "RELAY MEDICAL", "long_name": "Relay Medical Corp.", "summary": "Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company focuses on the development of novel technologies in the diagnostics and AI data science sectors. It provides HemoPalm, a handheld blood analyzer and single-use cartridge system for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an AI and data analytics driven personal medication management system for non-adherence to treatment. It also provides products and services related to the management of decentralized fleets of medical devices, and the data streams. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.", "currency": "EUR", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "FRA", "market": "dr_market", "country": "Canada", "city": "Toronto"}, "IZO.CN": {"short_name": "IzotropicCorp", "long_name": "Izotropic Corporation", "summary": "Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "CNQ", "market": "ca_market", "country": "Canada", "city": "Surrey"}, "IZOZF": {"short_name": "IZOTROPIC CORPORATION", "long_name": "Izotropic Corporation", "summary": "Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Surrey"}, "JUMP.V": {"short_name": "LEVELJUMP HEALTHCARE CORP", "long_name": "Leveljump Healthcare Corp.", "summary": "Leveljump Healthcare Corp. operates as a medical diagnostic imaging company. It offers teleradiology services to its client hospitals and imaging centers. The company is headquartered in Toronto, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "VAN", "market": "ca_market", "country": "Canada", "city": "Toronto"}, "MBI-H.V": {"short_name": "MED BIOGENE INC", "long_name": "Med BioGene Inc.", "summary": "Med BioGene Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based clinical tests for cancer. The company focuses on the commercialization of technologies in various industrial sectors. Med BioGene Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "VAN", "market": "ca_market", "country": "Canada", "city": "Vancouver"}, "RELA.CN": {"short_name": "RelayMedCorp", "long_name": "Relay Medical Corp.", "summary": "Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company focuses on the development of novel technologies in the diagnostics and AI data science sectors. It provides HemoPalm, a handheld blood analyzer and single-use cartridge system for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an AI and data analytics driven personal medication management system for non-adherence to treatment. It also provides products and services related to the management of decentralized fleets of medical devices, and the data streams. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "CNQ", "market": "ca_market", "country": "Canada", "city": "Toronto"}, "RYMDF": {"short_name": "RELAY MEDICAL CORP", "long_name": "Relay Medical Corp.", "summary": "Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The company focuses on the development of novel technologies in the diagnostics and AI data science sectors. It provides HemoPalm, a handheld blood analyzer and single-use cartridge system for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an AI and data analytics driven personal medication management system for non-adherence to treatment. It also provides products and services related to the management of decentralized fleets of medical devices, and the data streams. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Toronto"}, "SQD.V": {"short_name": "SQI DIAGNOSTICS INC.", "long_name": "SQI Diagnostics Inc.", "summary": "SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for multiplexing diagnostics in Canada. It offers a range of multiplexed products and services, including detecting and quantifying proteins, antibodies, and DNA. The company provides sqidworks, a workhorse system that enables to load plates and get report; sqidlite, a benchtop system, which allows processing one plate per run; and sqid-X that accesses various multiplexing power of Ig_plex technology with its semi-automated system. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. The company serves pharmaceutical and biotechnology drug development, human diagnostic testing, and animal health diagnostic testing markets. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "VAN", "market": "ca_market", "country": "Canada", "city": "Toronto"}, "SQIDF": {"short_name": "SQI DIAGNOSTICS INC", "long_name": "SQI Diagnostics Inc.", "summary": "SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for multiplexing diagnostics in Canada. It offers a range of multiplexed products and services, including detecting and quantifying proteins, antibodies, and DNA. The company provides sqidworks, a workhorse system that enables to load plates and get report; sqidlite, a benchtop system, which allows processing one plate per run; and sqid-X that accesses various multiplexing power of Ig_plex technology with its semi-automated system. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. The company serves pharmaceutical and biotechnology drug development, human diagnostic testing, and animal health diagnostic testing markets. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Toronto"}, "SZLS.TO": {"short_name": "STAGEZERO LIFE SCIENCES LTD", "long_name": "StageZero Life Sciences Ltd.", "summary": "StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. The company was formerly known as GeneNews Limited. StageZero Life Sciences Ltd. was founded in 1998 and is headquartered in Richmond Hill, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "TOR", "market": "ca_market", "country": "Canada", "city": "Richmond Hill"}, "TDSGF": {"short_name": "TELO GENOMICS CORP", "long_name": "Telo Genomics Corp.", "summary": "Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada.", "currency": "USD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "PNK", "market": "us_market", "country": "Canada", "city": "Toronto"}, "TELO.V": {"short_name": "TELO GENOMICS CORP", "long_name": "Telo Genomics Corp.", "summary": "Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides telomere analysis platform with diagnostic and prognostic applications; and solutions with liquid biopsies and related technologies in oncology and neurological diseases. The company's lead application is Telo-MM, a solution that provides actionable information to medical professionals in the treatment of Multiple Myeloma, a form of blood cancer. Its solutions also include TeloView, a proprietary software platform used to quantify specific features of each patient's telomeres. The company serves pathologists, clinicians, academic researchers, and drug developers. Telo Genomics Corp. has a collaboration agreement with the Mayo Clinic to validate its Telo-MM tests for multiple myeloma. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. Telo Genomics Corp. was incorporated in 2011 and is headquartered in Toronto, Canada.", "currency": "CAD", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "VAN", "market": "ca_market", "country": "Canada", "city": "Toronto"}, "XSQ.F": {"short_name": "SQI DIAGNOSTICS INC.", "long_name": "SQI Diagnostics Inc.", "summary": "SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for multiplexing diagnostics in Canada. It offers a range of multiplexed products and services, including detecting and quantifying proteins, antibodies, and DNA. The company provides sqidworks, a workhorse system that enables to load plates and get report; sqidlite, a benchtop system, which allows processing one plate per run; and sqid-X that accesses various multiplexing power of Ig_plex technology with its semi-automated system. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. The company serves pharmaceutical and biotechnology drug development, human diagnostic testing, and animal health diagnostic testing markets. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada.", "currency": "EUR", "sector": "Healthcare", "industry": "Diagnostics & Research", "exchange": "FRA", "market": "dr_market", "country": "Canada", "city": "Toronto"}}